82 related articles for article (PubMed ID: 21606589)
1. Immunostimulatory properties of glycated chitosan.
Zhou F; Song S; Chen WR; Xing D
J Xray Sci Technol; 2011; 19(2):285-92. PubMed ID: 21606589
[TBL] [Abstract][Full Text] [Related]
2. Glycated chitosan as a new non-toxic immunological stimulant.
Song S; Zhou F; Nordquist RE; Carubelli R; Liu H; Chen WR
Immunopharmacol Immunotoxicol; 2009 Jun; 31(2):202-8. PubMed ID: 19514994
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of laser cancer treatment by a chitosan-derived immunoadjuvant.
Chen WR; Korbelik M; Bartels KE; Liu H; Sun J; Nordquist RE
Photochem Photobiol; 2005; 81(1):190-5. PubMed ID: 15535737
[TBL] [Abstract][Full Text] [Related]
4. Effect of different components of laser immunotherapy in treatment of metastatic tumors in rats.
Chen WR; Liu H; Ritchey JW; Bartels KE; Lucroy MD; Nordquist RE
Cancer Res; 2002 Aug; 62(15):4295-9. PubMed ID: 12154032
[TBL] [Abstract][Full Text] [Related]
5. Biodegradable microspheres alone do not stimulate murine macrophages in vitro, but prolong antigen presentation by macrophages in vitro and stimulate a solid immune response in mice.
Luzardo-Alvarez A; Blarer N; Peter K; Romero JF; Reymond C; Corradin G; Gander B
J Control Release; 2005 Dec; 109(1-3):62-76. PubMed ID: 16269200
[TBL] [Abstract][Full Text] [Related]
6. Role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. II. Down-regulation of macrophage-mediated cytotoxicity by tumor-derived granulocyte-macrophage colony-stimulating factor.
Sotomayor EM; Fu YX; Lopez-Cepero M; Herbert L; Jimenez JJ; Albarracin C; Lopez DM
J Immunol; 1991 Oct; 147(8):2816-23. PubMed ID: 1918995
[TBL] [Abstract][Full Text] [Related]
7. Macrophages enhance the radiosensitizing activity of lipid A: a novel role for immune cells in tumor cell radioresponse.
De Ridder M; Verovski VN; Darville MI; Van Den Berge DL; Monsaert C; Eizirik DL; Storme GA
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):598-606. PubMed ID: 15380597
[TBL] [Abstract][Full Text] [Related]
8. Macrophage processing of antigen for induction of tumor immunity.
Brunda MJ; Raffel S
Cancer Res; 1977 Jun; 37(6):1838-44. PubMed ID: 66987
[TBL] [Abstract][Full Text] [Related]
9. Assessment of a combined, adenovirus-mediated oncolytic and immunostimulatory tumor therapy.
Bernt KM; Ni S; Tieu AT; Lieber A
Cancer Res; 2005 May; 65(10):4343-52. PubMed ID: 15899826
[TBL] [Abstract][Full Text] [Related]
10. Extracellular products from virulent strain of Edwardsiella tarda stimulate mouse macrophages (RAW264.7) to produce nitric oxide (NO) and tumor necrosis factor (TNF)-alpha.
Wang Y; Osatomi K; Yoshida A; Liang X; Kanai K; Oda T; Hara K
Fish Shellfish Immunol; 2010 Nov; 29(5):778-85. PubMed ID: 20633653
[TBL] [Abstract][Full Text] [Related]
11. IL-11-induced reduction of C/EBP transcription factor binding may contribute to the IL-12 downregulation in tumor-bearing mice.
Torroella-Kouri M; Keith JC; Ivanova M; Lopez DM
Int J Oncol; 2003 Feb; 22(2):439-48. PubMed ID: 12527946
[TBL] [Abstract][Full Text] [Related]
12. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
Ferret-Bernard S; Saï P; Bach JM
Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
[TBL] [Abstract][Full Text] [Related]
13. Biodegradable chitosan particles induce chemokine release and negligible arginase-1 activity compared to IL-4 in murine bone marrow-derived macrophages.
Guzmán-Morales J; Ariganello MB; Hammami I; Thibault M; Jolicoeur M; Hoemann CD
Biochem Biophys Res Commun; 2011 Feb; 405(4):538-44. PubMed ID: 21256824
[TBL] [Abstract][Full Text] [Related]
14. Virulizin, a novel immunotherapy agent, stimulates TNFalpha expression in monocytes/macrophages in vitro and in vivo.
Li H; Cao MY; Lee Y; Benatar T; Lee V; Feng N; Gu X; Liu P; Jin H; Wang M; Der S; Lightfoot J; Wright JA; Young AH
Int Immunopharmacol; 2007 Oct; 7(10):1350-9. PubMed ID: 17673150
[TBL] [Abstract][Full Text] [Related]
15. Chitosan oligosaccharide (COS) inhibits LPS-induced inflammatory effects in RAW 264.7 macrophage cells.
Yoon HJ; Moon ME; Park HS; Im SY; Kim YH
Biochem Biophys Res Commun; 2007 Jul; 358(3):954-9. PubMed ID: 17512902
[TBL] [Abstract][Full Text] [Related]
16. Expansion of immunoregulatory macrophages by granulocyte-macrophage colony-stimulating factor derived from a murine mammary tumor.
Fu YX; Watson G; Jimenez JJ; Wang Y; Lopez DM
Cancer Res; 1990 Jan; 50(2):227-34. PubMed ID: 2136804
[TBL] [Abstract][Full Text] [Related]
17. Dual beta-adrenergic modulation in the immune system: stimulus-dependent effect of isoproterenol on MAPK activation and inflammatory mediator production in macrophages.
Szelenyi J; Selmeczy Z; Brozik A; Medgyesi D; Magocsi M
Neurochem Int; 2006 Jul; 49(1):94-103. PubMed ID: 16515823
[TBL] [Abstract][Full Text] [Related]
18. Modulation of TNFalpha, IL-10 and IL-12p40 levels by a ceramide-1-phosphate analog, PCERA-1, in vivo and ex vivo in primary macrophages.
Avni D; Goldsmith M; Ernst O; Mashiach R; Tuntland T; Meijler MM; Gray NS; Rosen H; Zor T
Immunol Lett; 2009 Mar; 123(1):1-8. PubMed ID: 19185589
[TBL] [Abstract][Full Text] [Related]
19. Treating tumor-bearing mice with low-dose gamma-interferon plus tumor necrosis factor alpha to diminish immune suppressive granulocyte-macrophage progenitor cells increases responsiveness to interleukin 2 immunotherapy.
Pak AS; Ip G; Wright MA; Young MR
Cancer Res; 1995 Feb; 55(4):885-90. PubMed ID: 7850804
[TBL] [Abstract][Full Text] [Related]
20. Chitooligosaccharides in combination with interferon-gamma increase nitric oxide production via nuclear factor-kappaB activation in murine RAW264.7 macrophages.
Wu GJ; Tsai GJ
Food Chem Toxicol; 2007 Feb; 45(2):250-8. PubMed ID: 17107743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
